MedPath

The effect of pomegranate juice and exercise on prostate cancer

Phase 1
Conditions
prostate cancer.
Registration Number
IRCT20200901048588N1
Lead Sponsor
Khoram-Abad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
60
Inclusion Criteria

Failure to perform radiation therapy, chemotherapy and androgen therapy
Do not perform any surgery
> PSA 6 as a benchmark for the study process
Lack of continuous exercise before starting the exercise program

Exclusion Criteria

Perform specialized treatments such as chemotherapy and radiation therapy in the last 6 months
Perform prostate cancer related surgeries
having cardiovascular disease, diabetes and neurological diseases
Alcohol consumption, smoking
Cancer cell metastasis and involvement of other tissues and organs in the body

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MicroRNA-21,microRNA-34,microRNA-155. Timepoint: 48 hours before and after eight weeks of aerobic exercise and consumption of pomegranate juice. Method of measurement: Real time-PCR device.
Secondary Outcome Measures
NameTimeMethod
Prostate-Specific Antigen (PSA),Superoxide dismutase(SOD),Glutathione peroxidase(GPX),Malondialdehyde(MDA). Timepoint: 48 hours before and after the performance, eight weeks of aerobic training and consumption of pomegranate juice. Method of measurement: ELISA device.
© Copyright 2025. All Rights Reserved by MedPath